Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In AMMO To Contact Him Directly To Discuss Their Options NEW YORK CITY, NY / ACCESSWIRE / October 13, 2024 / If you suffered losses exceeding $50,000 in AMMO between August 19, 2020 and September 24, 2024 and […]

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Paragon 28 To Contact Him Directly To Discuss Their Options NEW YORK CITY, NY / ACCESSWIRE / October 13, 2024 / If you suffered losses exceeding $75,000 in Paragon 28 between May 5, 2023 and August 8,

Expediting International Clinical Trials for Pivotal Products Key Participants Include International Long-Term and Healthcare Funds Akeso Biopharma (9926.HK) (“Akeso”, the “Company” ) announced that it has successfully raised approximately $250 million USD through a share placement. This offering has earned notable recognition among international investment firms, with the majority of our final subscribers being long-term

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In UPS To Contact Him Directly To Discuss Their Options NEW YORK CITY, NY / ACCESSWIRE / October 13, 2024 / If you suffered losses exceeding $100,000 in UPS between January 30, 2024 to July 22, 2024 and

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Symbotic To Contact Him Directly To Discuss Their Options NEW YORK CITY, NY / ACCESSWIRE / October 13, 2024 / If you suffered losses exceeding $100,000 in Symbotic between May 6, 2024 and July 29, 2024 and

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In New Fortress To Contact Him Directly To Discuss Their Options NEW YORK CITY, NY / ACCESSWIRE / October 13, 2024 / If you suffered losses exceeding $50,000 in New Fortress between February 9, 2024, and August 8,

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Extreme Networks To Contact Him Directly To Discuss Their Options NEW YORK CITY, NY / ACCESSWIRE / October 13, 2024 / If you suffered losses exceeding $100,000 in Extreme Networks between July 27, 2022 and January 30,

NEW YORK, Oct. 13, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Stellantis N.V. (NYSE: STLA) between February 15, 2024 and July 24, 2024, both dates inclusive (the “Class Period”), of the important October 15, 2024 lead plaintiff deadline. SO WHAT: If you purchased

NEW YORK, NY / ACCESSWIRE / October 13, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of ADMA Biologics, Inc. ("ADMA Biologics, Inc.") (NASDAQ:ADMA) concerning possible violations of federal securities laws. On October 9, 2024, ADMA Biologics disclosed the surprise resignation of its independent outside auditor CohnReznick LLP. The news

NEW YORK, NY / ACCESSWIRE / October 13, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of The Toronto-Dominion Bank ("The Toronto-Dominion Bank") (NYSE:TD) concerning possible violations of federal securities laws. On October 10, 2024, TD Bank issued a press release announcing the resolution of the AML investigations into the